| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |